Related Experiment Videos
Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1
L M Huang1, M F Chao, M Y Chen
1Department of Pediatrics, National Taiwan University Hospital, National Health Research Institutes, Taipei 100, Taiwan. lmhuang@ha.mc.ntu.edu.tw
The Journal of Biological Chemistry
|January 23, 2001
Summary
Human herpesvirus 8 (HHV8) and human immunodeficiency virus type 1 (HIV-1) coinfection synergistically increases Kaposi's sarcoma risk. These viruses reciprocally enhance each other's gene expression, contributing to disease pathogenesis.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Human herpesvirus 8 (HHV8) is the primary cause of Kaposi's sarcoma (KS).
- Coinfection with HHV8 and human immunodeficiency virus type 1 (HIV-1) significantly increases KS prevalence.
- HIV-1-induced immune suppression alone does not fully account for the heightened KS incidence in coinfected individuals.
Purpose of the Study:
- To investigate potential direct regulatory interactions between HHV8 and HIV-1 in KS pathogenesis.
- To elucidate the molecular mechanisms underlying the enhanced KS risk in HHV8/HIV-1 coinfection.
Main Methods:
- Analyzing gene expression regulation between HHV8 and HIV-1.
- Investigating the interaction between HHV8 KIE2 protein and HIV-1 Tat in activating the HIV-1 long terminal repeat.
- Assessing the effect of HIV-1 Tat and Vpr proteins on HHV8 gene expression.
Main Results:
- HHV8 and HIV-1 reciprocally up-regulate each other's gene expression.
- HHV8 KIE2 protein synergistically enhances Tat-mediated activation of the HIV-1 long terminal repeat.
- HIV-1 Tat and Vpr proteins increase intracellular HHV8 gene expression.
Conclusions:
- HHV8 and HIV-1 exhibit reciprocal gene expression regulation.
- These viral interactions provide molecular insights into the increased incidence of KS during coinfection.
- Understanding these interactions is crucial for developing targeted therapies against KS in coinfected patients.